open access publication

Article, 2024

No Detectable Differences in microRNA Plasma Levels between Diabetic Hypertensive Patients with and without Incident Subclinical Atrial Fibrillation

JOURNAL OF CLINICAL MEDICINE, ISSN 2077-0383, 2077-0383, Volume 13, 9, 10.3390/jcm13092554

Contributors

Feddersen, Soren [1] [2] Philippsen, Tine J. [3] Hansen, M. Stormly 0000-0001-8610-7455 [3] Christensen, L. Svendstrup [3] Nybo, Mads [1] [2] Brandes, Axel 0000-0001-9145-6887 (Corresponding author) [1] [2] [4]

Affiliations

  1. [1] Odense Univ Hosp, Dept Clin Biochem, JB Winslows Vej 4, DK-5000 Odense, Denmark
  2. [NORA names: Region of Southern Denmark; Hospital; Denmark; Europe, EU; Nordic; OECD];
  3. [2] Odense Univ Hosp, Dept Clin Biochem, JB Winslows Vej 4, DK-5000 Odense, Denmark
  4. [NORA names: SDU University of Southern Denmark; University; Denmark; Europe, EU; Nordic; OECD];
  5. [3] Hosp Southern Jutland, Dept Cardiol, Kresten Philipsens Vej 15, DK-6200 Aabenraa, Denmark
  6. [NORA names: Region of Southern Denmark; Hospital; Denmark; Europe, EU; Nordic; OECD];
  7. [4] Univ Southern Denmark Esbjerg, Dept Reg Hlth Res, Finsensgade 35, DK-6700 Esbjerg, Denmark
  8. [NORA names: SDU University of Southern Denmark; University; Denmark; Europe, EU; Nordic; OECD]

Abstract

Background: Long-term rhythm monitoring (LTRM) can detect undiagnosed atrial fibrillation (AF) in patients at risk of AF and stroke. Circulating microRNAs (miRNAs), which have been shown to play a role in atrial electrical and structural remodelling, could help to select patients who would benefit most from LTRM. The aim of this study was to investigate whether patients with diabetes mellitus (DM) and hypertension and screen-detected subclinical AF (SCAF) using an insertable cardiac monitor (ICM) have significantly different plasma baseline levels of five selected miRNAs playing a role in the modulation of atrial electrical and structural remodelling (miR-21-5p, miR-29b-3p, miR-150-5p, miR-328-3p, and miR-432-5p) compared to those without SCAF. Methods: This study was performed at the outpatient clinic of a secondary academic teaching hospital between December 2013 and November 2015. Eligible patients were >= 65 years of age with DM and hypertension but without known heart diseases. All patients received an ICM. On the day of ICM implantation, blood samples for the measurement of plasma levels of the five miRNAs were drawn. In this post hoc analysis, we investigated their expression by reverse transcription-quantitative polymerase chain reaction. MiRNA plasma levels in patients with and without newly detected SCAF were compared. Results: We included 82 consecutive patients (median age of 71.3 years (IQR 67.4-75.1)), who were followed for a median of 588 days (IQR: 453-712 days). Seventeen patients (20.7%) had ICM-detected SCAF. Plasma levels of miR-328-3p, miR-29b-3p, miR-21-5p, miR-432-5p, and miR-150-5p were slightly but not significantly different in patients with incident SCAF compared with patients without. Conclusions: In patients with hypertension and DM, newly detected SCAF was not significantly associated with changes in expression levels of miR-21-5p, miR-29b-3p, miR-150-5p, miR-328-3p, and miR-432-5p.

Keywords

electrical remodelling, insertable cardiac monitor, microRNA, structural remodelling, subclinical atrial fibrillation

Data Provider: Clarivate